The "Vanguards of Health Care" podcast features Matt Henriksson from Bloomberg Intelligence interviewing Massimo Calafiore, CEO of Orthofix, a medical device company. Calafiore discusses his career path, what attracted him to Orthofix, and the changes he's implemented, including building a team of experts. The conversation covers Orthofix's diversified market segments—spine, orthopedics, and bone growth—and the evolution of these markets. A significant focus is on Orthofix's 7D navigation system, its advantages, and its impact on surgical procedures. They explore the pull-through opportunities with the 7D system, hospital purchasing decisions, and potential future incorporation of robotics. The discussion shifts to Orthofix's orthopedic segment, particularly limb reconstruction and diabetic foot ulcers, and the role of enabling technology. Finally, they touch on bone growth therapy, capital allocation strategies, and the company's approach to M&A, emphasizing profitable growth and stakeholder value.
Sign in to continue reading, translating and more.
Continue
